# Dominica Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Dominica HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Dominica (DMA)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $3.3M
- Products: 24
- Buyer markets: 16
- Average CAGR: +0.9%
- Global sector size: $255.1B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $178.4B | $93.6K | $68.9B | -19.3% | 10 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.2B | $332.2 | $8.5B | -11.7% | 4 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $10.7B | $7.9K | $5.9B | -3.0% | 6 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $14.0B | $642.6 | $4.6B | -20.1% | 6 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $8.7B | $2.9K | $3.6B | +40.6% | 1 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $9.2B | $1.7K | $3.4B | -10.3% | 3 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $5.7B | $16.9 | $3.0B | -7.8% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $2.3B | $3.7K | $2.1B | +10.3% | 2 | +0.0% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $3.0B | $1.9M | $2.0B | +139.7% | 1 | +0.2% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $1.5B | $10.3K | $1.4B | -0.2% | 2 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $1.4 | $1.2B | -27.6% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $2.0B | $3.3K | $1.2B | +78.1% | 2 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $1.5B | $1.1M | $935.4M | +15.3% | 1 | +3.0% |
| HS 340130 - Organic surface-active products and preparations for washing the skin, in the form of liquid or cream and put up for retail sale, whether or not containing soap | $1.2B | $73.3 | $855.9M | -12.6% | 2 | +0.0% |
| HS 330590 - Hair preparations: n.e.s. in heading no. 3305 | $1.8B | $1.1K | $755.4M | +7.1% | 2 | +0.0% |
| HS 340600 - Candles, tapers and the like | $1.0B | $3.3K | $640.9M | +32.3% | 1 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $688.2M | $2.9K | $638.3M | +40.6% | 1 | +0.0% |
| HS 300660 - Pharmaceutical goods: chemical contraceptive preparations based on hormones or spermicides | $1.2B | $207.5 | $604.6M | +103.0% | 1 | +0.0% |
| HS 300610 - Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents, absorbable surgical or dental haemostatics, and surgical or dental adhesion barriers | $393.8M | $4.4K | $485.0M | +19.6% | 1 | +0.0% |
| HS 280429 - Gases, rare: other than argon | $584.4M | $21.8 | $453.4M | -54.7% | 1 | +0.0% |
| HS 340119 - Soap and organic surface-active products: in the form of bars, cakes, moulded shapes, and paper, wadding, felt and nonwovens, impregnated, coated or covered with soap or detergent, not for toilet use | $403.3M | $324.5 | $313.4M | -9.1% | 1 | +0.0% |
| HS 350790 - Enzymes and prepared enzymes: other than rennet and concentrates thereof | $989.3M | $152.3K | $310.3M | -12.6% | 1 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $615.5M | $2.9K | $303.8M | +40.6% | 1 | +0.0% |
| HS 330610 - Oral or dental hygiene preparations: dentifrices | $297.4M | $2.3 | $292.5M | -28.0% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $36.5B calculated opportunity across 15 products.
- Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products.
- Canada (CAN): $8.6B calculated opportunity across 7 products.
- France (FRA): $6.6B calculated opportunity across 7 products.
- Netherlands (NLD): $6.6B calculated opportunity across 3 products.
- United Kingdom (GBR): $6.5B calculated opportunity across 4 products.
- Japan (JPN): $4.6B calculated opportunity across 3 products.
- China (CHN): $4.2B calculated opportunity across 3 products.
- Ireland (IRL): $3.2B calculated opportunity across 1 products.
- Taiwan (TWN): $3.0B calculated opportunity across 2 products.
- Germany (DEU): $1.6B calculated opportunity across 2 products.
- Republic of Korea (KOR): $1.1B calculated opportunity across 1 products.

## Growth stars

- HS 381800: +139.7% average CAGR, $2.0B calculated opportunity.
- HS 300660: +103.0% average CAGR, $604.6M calculated opportunity.
- HS 330290: +78.1% average CAGR, $1.2B calculated opportunity.
- HS 300215: +40.6% average CAGR, $3.6B calculated opportunity.
- HS 300214: +40.6% average CAGR, $638.3M calculated opportunity.
- HS 300212: +40.6% average CAGR, $303.8M calculated opportunity.
- HS 340600: +32.3% average CAGR, $640.9M calculated opportunity.
- HS 300610: +19.6% average CAGR, $485.0M calculated opportunity.
- HS 300220: +15.3% average CAGR, $935.4M calculated opportunity.
- HS 340220: +10.3% average CAGR, $2.1B calculated opportunity.

## Diversification opportunities

- HS 300490: 10 buyer markets, $68.9B calculated opportunity.
- HS 330300: 6 buyer markets, $5.9B calculated opportunity.
- HS 330499: 6 buyer markets, $4.6B calculated opportunity.
- HS 330210: 4 buyer markets, $8.5B calculated opportunity.
- HS 382200: 3 buyer markets, $3.4B calculated opportunity.
- HS 340220: 2 buyer markets, $2.1B calculated opportunity.
- HS 370790: 2 buyer markets, $1.4B calculated opportunity.
- HS 330290: 2 buyer markets, $1.2B calculated opportunity.
- HS 340130: 2 buyer markets, $855.9M calculated opportunity.
- HS 330590: 2 buyer markets, $755.4M calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.